Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Int J STD AIDS ; 35(5): 379-388, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38166231

RESUMO

BACKGROUND: Men who have sex with men (MSM) are at risk for sexually transmitted infections (STIs), but more data on extragenital carriage are needed. AIM: We assessed the genital and extragenital prevalence of bacterial and other STIs in MSM in a Lisbon sexual health clinic. METHODS: We screened oral, anal, and urine samples of MSM visiting the GAT-CheckpointLX clinic June 2017-December 2021 for Chlamydia trachomatis (including lymphogranuloma venereum, LGV), Neisseria gonorrhoeae, Mycoplasma genitalium, Trichomonas vaginalis, Mycoplasma hominis, Ureaplasma urealyticum, and U. parvum. Ano-oro-genital lesions were tested for LGV, Treponema pallidum, and Herpes Simplex Virus. Blood was tested for HIV and T. pallidum antibodies. RESULTS: N. gonorrhoeae was found in 16.6% of the MSM followed by C. trachomatis (13.2%), M. genitalium (10.3%) and T. vaginalis (0.2%). The most frequent occurrence was anorectal (C. trachomatis, M. genitalium) and oral (N. gonorrhoeae). We found high carriage of U. urealyticum (36.1%) and M. hominis (22.1%). LGV was detected in 21.8% of chlamydia-positive anorectal swabs. Syphilis was detected in 22.6% of tested MSM, while 13.8% had HIV. Gonorrhoea and chlamydia were significantly more prevalent in MSM with concomitant HIV or syphilis. CONCLUSION: The substantial extragenital prevalence of bacterial STIs in MSM, and HIV and syphilis coinfections, suggest screening has value in identifying hidden carriage and in contributing for providing better care.


Assuntos
Doenças do Ânus , Infecções por Chlamydia , Gonorreia , Infecções por HIV , Linfogranuloma Venéreo , Infecções por Mycoplasma , Mycoplasma genitalium , Minorias Sexuais e de Gênero , Infecções Sexualmente Transmissíveis , Sífilis , Masculino , Humanos , Chlamydia trachomatis , Neisseria gonorrhoeae , Homossexualidade Masculina , Infecções por Mycoplasma/diagnóstico , Infecções Sexualmente Transmissíveis/epidemiologia , Gonorreia/diagnóstico , Infecções por HIV/epidemiologia , Infecções por Chlamydia/diagnóstico , Prevalência
2.
AIDS Res Hum Retroviruses ; 21(4): 249-55, 2005 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15943566

RESUMO

Human T cell lymphotropic virus type 2 infections can be found in the large urban areas of the United States and Europe, where Spain and Italy are the most affected countries. The population most affected by the epidemic is characterized by high-risk behavior groups, mainly the sharing of needles between intravenous drug users (IDUs) with contaminated cellular blood products. It is also described that HTLV-2 infection appears as a coinfection with HIV-1. We have selected samples corresponding to 583 IDUs infected with HIV and screened for the presence of HTLV-1/2 antibodies. We have performed the molecular characterization of HTLV-2 in three confirmed positive cases on the basis of the long terminal repeat region. We can observe the Portuguese sequences (PortHl, PortNn, and PortVs) in the HTLV-2b cluster, grouping with the Spanish sequences, showing close phylogenetic relatedness. We may assume that HTLV-2 infection was introduced in Portugal from Spain. These results update previous reports that mentioned Portugal as being free of HTLV- 2 infections, and allow the identification of the subtype that is present, giving a first-hand description of the prevalence of HTLV-2 infection in a particular high-risk behavior group and justifying the importance of epidemiological surveillance in order to prevent dissemination of the infection.


Assuntos
Infecções por HIV/complicações , HIV-1 , Infecções por HTLV-II/virologia , Vírus Linfotrópico T Tipo 2 Humano/genética , Abuso de Substâncias por Via Intravenosa/complicações , Sequência de Bases , Feminino , Anticorpos Anti-HTLV-I/sangue , Anticorpos Anti-HTLV-II/sangue , Infecções por HTLV-II/complicações , Infecções por HTLV-II/epidemiologia , Vírus Linfotrópico T Tipo 2 Humano/isolamento & purificação , Humanos , Masculino , Epidemiologia Molecular , Dados de Sequência Molecular , Filogenia , Portugal/epidemiologia , RNA Viral/genética , Alinhamento de Sequência , Sequências Repetidas Terminais/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA